We’d like to bring to your attention a new funding opportunity announcement that may be relevant to you or your collaborators? Please feel free to share.
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases, National Institute of Mental Health
The overall goal of this FOA is to foster basic science research to address outstanding questions in HIV latency and persistence. The scientific objective is to harness innovative single-cell and multi-omics platforms to investigate mechanisms of HIV persistence at the single-cell level with greater precision and higher resolution than has been achieved previously using traditional techniques. Emphasis will be on multi-omics or parallel approaches integrating multiple cutting-edge single-cell analysis technologies. These combinatorial approaches will enable highly innovative basic HIV research to characterize pathways, factors, and biomarkers involved in HIV persistence, latency, latency reversal, killing of reservoir cells, viral recrudescence or rebound, and control of viremia. The objectives are to facilitate interdisciplinary research among bioinformaticians, bioengineers, HIV basic scientists, and HIV clinicians with access to relevant clinical specimens.
This is a one-time RFA, with a due date of March 13, 2019, by 5:00 PM local time of applicant organization.
Please do not hesitate to contact me with any questions, happy to help! Thank you for your consideration.
Lillian S. Kuo, Ph.D.
Pathogenesis & Basic Research Branch
Basic Sciences Program, Division of AIDS
National Institute of Allergy and Infectious Diseases
5601 Fishers Lane #9G37
Bethesda, MD 20892-9830 (deliveries use Rockville, MD 20852)
phone: +1 (240) 292-4621
Check out NIAID funding opportunities here: https://www.niaid.nih.gov/grants-contracts/opportunities